Sequenom sex determination test
This article was originally published in The Gray Sheet
Executive Summary
Sequenom has launched its CLIA-laboratory-developed SensiGene Fetal (XY) fetal sex determination test, providing physicians with "accurate and noninvasive" fetal testing, firm announces Feb. 16. The test, which relies on a blood sample taken in a doctor's office and is performed on Sequenom's MassARRAY system, has a turnaround time of about one week. It showed a sensitivity of 97.9% and a specificity of 100% in a blinded study with over 200 samples evaluated at the Albert Einstein Medical Center in Philadelphia